Archives of the Turkish Society of Cardiology
Clinical studies conducted with new oral anticoagulants in atrial fibrillation: Which oral anticoagulant can be considered for which case in light of the clinical studies? [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2016; 44(2): 33-40

Clinical studies conducted with new oral anticoagulants in atrial fibrillation: Which oral anticoagulant can be considered for which case in light of the clinical studies?

Necla Özer
Hacettepe Üniversitesi Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Ankara

Not only atrial fibrillation is the most frequently seen arrhythmias, but also a crucial health problem due to the increased stroke and embolism risk. For patients with atrial fibrillation, the anticoagulation therapy is quite important to prevent stroke and thromboembolism. In recent years, in addition to the warfarin, new oral anticoagulants have started in our clinical practice. In this review, important works which have been done with the new anticoagulants and their reflections on our clinical practice have been tried to be summarized.

Keywords: Atrial fibrillation, embolism, anticoagulants.

How to cite this article
Necla Özer. Clinical studies conducted with new oral anticoagulants in atrial fibrillation: Which oral anticoagulant can be considered for which case in light of the clinical studies?. Turk Kardiyol Dern Ars. 2016; 44(2): 33-40

Corresponding Author: Necla Özer, Türkiye
© Copyright 2020 Archives of the Turkish Society of Cardiology
LookUs & Online Makale